Your Ad Here

DRUG FOR HEALTH

Your portal to updated news on the world of medicines and drugs

Sunday 30 May 2010

Brush teeth to 'prevent' heart disease

People who fail to brush their teeth twice a day are putting themselves at risk of heart disease, research suggests.

The Scottish study of more than 11,000 adults backs previous research linking gum disease with heart problems.

The researchers said more work is needed to confirm if poor oral health directly causes heart disease or is a marker of risk.

A charity added that oral hygiene was just one factor in good heart health.

Data, published in the British Medical Journal was collected on lifestyle behaviours, such as smoking, physical activity and oral health routines.

Participants were also asked how often they visited the dentist and how often they brushed their teeth.

Then nurses collected information on medical history and family history of heart disease, took blood pressure and blood samples.

Overall, six out of 10 people said they visited the dentist every six months and seven out 10 reported brushing their teeth twice a day.

Over the eight-year study there were 555 "cardiovascular events" such as heart attacks, 170 of which were fatal.

Cause and effect

Study leader Professor Richard Watt, from University College London, said future studies will be needed to confirm whether the link between oral health behaviour and cardiovascular disease "is in fact causal or merely a risk marker".

Judy O'Sullivan, senior cardiac nurse at British Heart Foundation, said: "If you don't brush your teeth, your mouth can become infected with bacteria which can cause inflammation.

"However, it is complicated by the fact that poor oral hygiene is often associated with other well known risk factors for heart disease, such as smoking and poor diet."

She added: "Good personal hygiene is a basic element of a healthy lifestyle.

"But if you want to help your heart, you should eat a balanced diet, avoid smoking and take part in regular physical activity."

Professor Damien Walmsley, scientific adviser to the British Dental Association, added it was still unclear whether there was a definite cause and effect between oral hygiene and heart disease.

"Whatever the true position is, we can say with certainty that if people brush teeth twice a day with fluoride toothpaste, visit the dentist regularly and restrict sugary snacks to mealtimes; that this will go a long way towards keeping the teeth and gums in a healthy state for life."

Friday 21 May 2010

New hope for better treatment for a rising cancer

New hope for better treatment for a rising cancer

Poor diet, too much alcohol, smoking and increasing obesity could be leading to an epidemic of oesophageal and upper stomach cancer, according to a leading UK team of specialists at The University of Nottingham and Nottingham University Hospitals.

The Nottingham Gastro-Oesophageal Cancer Research Group has been carrying out intensive research over the past five years to try to improve the treatment of this cancer. A major part of the research is published today in the British Journal of Cancer. The work has been prompted by a large increase in the incidence of cancer of the oesophagus (gullet) and upper stomach over the past 40 years.

According to Cancer Research UK statistics, rates of oesophageal adenocarcinoma and gastro-oesophageal (GOJ) adenocarcinoma have been increasing in the UK. Since the 1970s the incidence of this cancer has increased by 50 per cent in men and 20 per cent in women. Indeed the reported rates for white men in the UK are now the highest in the world.

Doctors believe changes in diet and lifestyle are the key factors behind the rapid rise in the number of cases. This new research is aimed at providing a better treatment and prognosis for a cancer that is historically not survivable past five years from diagnosis. Current standard treatment for potentially operable cancer consists of a 12 week intensive course of powerful chemotherapy, followed by surgery if the tumour is operable, and then a second 12 week course of chemotherapy. This prolonged, intense course of chemotherapy treatment is potentially toxic, impacts on quality of life and is likely to be beneficial only in those patients who respond to chemotherapy.

The Nottingham-based research using molecular cancer pathology and DNA protein expression techniques on tumour samples from around 250 patients after surgery has shown that only between 40 per cent and 50 per cent of these adenocarcinomas actually respond to the chemotherapy. The research has effectively tested a very promising monitoring test during treatment so that doctors can assess whether and how far the tumour is regressing during chemotherapy. In addition, the research has also identified a promising protein marker involved in DNA repair in cancer cells that predicts resistance to chemotherapy in tumours.

The new information could empower doctors to decide whether to recommend a second course of powerful chemotherapy after surgery. The research also paves the way for wider and more specialised clinical trials for this cancer which will monitor patients in real-time, rather than using past samples, and which could lead to new combinations of chemotherapy, including the new breast cancer drug, Herceptin, which has recently been proven to be effective in gastro-oesophageal cancers.

Dr Srinivasan Madhusudan, Clinical Associate Professor & Consultant in Medical Oncology at Nottingham University Hospitals and the University’s School of Molecular Medical Sciences, said: “Recent scientific advances have given real hope for patients with gastro-oesophageal cancers. The Nottingham Upper Gastrointestinal Cancer Group is a multidisciplinary research team consisting of Oncologists, Surgeons, Pathologists and Radiologists. We aim to exploit the ‘new science’ for patient benefit. This study published online today in the British Journal of Cancer provides evidence that it may be possible to tailor gastro-oesophageal cancer treatments based on ‘new’ biology. We are planning a larger prospective multicentre study to confirm these findings and we believe will have major clinical impact on how we treat these aggressive tumours in the future.”

Source:http://communications.nottingham.ac.uk/News/

Friday 7 May 2010

Unravelling the health-giving properties of fruit and veg

Unravelling the health-giving properties of fruit and veg


Scientists at The University of Nottingham are to use their share of a unique £6.5m research award to discover which genes control the health promoting properties of fruit and vegetables.

As part of a cross-channel partnership to enhance international collaboration in Systems Biology Graham Seymour, Professor of Plant Biotechnology, and Charlie Hodgman, Director of the Centre for Plant Integrative Biology, will be working on a systems biology approach to understand the metabolic networks underlying health based quality traits in tomato fruit.

With their award of nearly £300,000 from the Biotechnology and Biological Sciences Research Council (BBSRC) and the Agence Nationale de la Recherche (ANR) the bio-scientists will be working in collaboration with Royal Holloway University of London, the National Scientific Research Centre, Paris (CNRS) and the Plant Genomics Centre, INRA, Evry, near Paris.

Professor Seymour said: “The health promoting properties of diets rich in fruit and vegetables has been attributed to the synergistic effects of various phytochemicals in food such as vitamins, flavonoids and carotenoids.

"This project aims to study an experimental model tomato that has very high levels of these health-related compounds. The researchers aim to use a systems biology approach to integrate information at many different levels about the tomato and to produce a predictive model of how the formation of these phytochemicals is controlled.”

Professor Hodgman said: "The long-term intention of the Centre for Plant Integrative Biology which is funded by the BBSRC and the Engineering and Physical Sciences Research Council is to apply work and techniques developed on model plant organisms to crop species. This tomato work is a very welcome first step."

BBSRC and ANR, the leading public life-science funding agencies in the UK and France, are funding a total of 10 new projects involving 22 different universities and institutes in the UK and France.

Each project has at least one UK and one French partner institution and the initiative aims to build European collaboration in Systems Biology. BBSRC has already invested over £70m in UK and European Systems Biology initiatives and the UK is one of the world leaders in this new and growing approach to tackling bioscience problems.

Systems biology is a revolution in the way bioscientists think and work. It brings together researchers across different disciplines, combining theory, computer modelling and experiments. Systems biology will make the outputs of bioscience research more useful and easier to apply in the real world, as well as advancing our understanding of biological processes.

The new projects will give the researchers involved access to complementary expertise and skills and will help develop the field of Systems Biology by coordinating BBSRC and ANR resources.

Mr Steve Visscher, BBSRC Interim Chief Executive, said: “Systems Biology holds great promise for delivering real, practical advances in healthcare, biotechnology and environmental research much faster than traditional biology. Collaborative initiatives with international partners enable us to increase the impact of our funding and the impact of the research being done by our scientists.

“We have been pleased to see that not only has the partnership between BBSRC and ANR resulted in a successful initiative but that the range and quality of the projects funded is also broadening the areas being studied by Systems Biology.”

Mrs Jacqueline Lecourtier, ANR General Manager, said: “As a young agency created in 2005, this was the first bilateral call undertaken within the Health & Biology Department. By answering this call, Systems Biology growing communities showed that they were ready to share their views and expertises. Moreover, this initiative allowed BBSRC and ANR to fund high quality and cross-disciplinary proposals, which is one of our missions.

“ANR and BBSRC cooperation was very successful on both levels, management and scientific. Future collaborations involving additional countries are already on their way through the ERANET ERASysBio.”

Source:http://communications.nottingham.ac.uk/News/

Do chemicals in the environment affect fertility?

Do chemicals in the environment affect fertility?


The amount of chemicals absorbed is thought to be so minute that they would be difficult to discern through testing. However, through a process known as bioaccumulation, chemicals can become concentrated in individuals over a number of years, stored mostly in fat tissue. Though these chemicals may not be directly harmful to these individuals, if they are passed on — for example, through gestation in the womb or through the food chain — they might have consequences for human health.

“One of the concerns of bioaccumulation is that when the fat is broken down and passed on — for example during the breast feeding process — the offspring are exposed to a concentration of chemicals that the mother has built up over the years,” said Dr Sinclair.

Colleagues in Aberdeen have provided precise measurements of specific chemicals in the environment and in animal tissues. These often take the form of chemicals which mimic hormones.

“These chemicals come from a variety of sources including plastics, pesticides and industrial waste and many of these persist in the environment for a long time — albeit at very low levels,” said Dr Lea. “The problem is even low levels can still have an effect.”

The three-year study will look at how chemicals are passed on from mother to foetus, and how this impacts on the foetus. It is thought that, although this generation of animals may have no problems getting pregnant, the next and future generations could have fertility problems stemming from exposure to environmental chemicals in the womb.

Dr Lea said: “Though male fertility has been the subject of studies in recent years, this will be the first time that female fertility has been examined. Currently, less is known about the effects of hormone-like chemicals on the developing female foetus, so the consequences for reproductive development in females may be greater than in males.”

“We're not talking about obvious congenital defects here, but tiny changes caused by exposure to chemicals that have an impact on reproductive function — changes over generations rather than immediate effect,” added Dr Sinclair.

The inaugural meeting of the REEF consortium will take place in Copenhagen on Thursday 22 and Friday 23 May to formally launch the project.

Source:http://communications.nottingham.ac.uk/News/